0001078782-16-002145.txt : 20160804 0001078782-16-002145.hdr.sgml : 20160804 20160107152753 ACCESSION NUMBER: 0001078782-16-002145 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20160107 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CEN BIOTECH INC CENTRAL INDEX KEY: 0001653821 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 20 N REAR RD CITY: LAKESHORE STATE: A6 ZIP: N0R 1A0 BUSINESS PHONE: 226-344-0660 MAIL ADDRESS: STREET 1: 20 N REAR RD CITY: LAKESHORE STATE: A6 ZIP: N0R 1A0 CORRESP 1 filename1.htm SEC Response Letter


CEN BIOTECH, INC.





January 8, 2016


Suzanne Hayes, Assistant Director

Office of Healthcare and Insurance

U.S. Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549


Re:

CEN Biotech, Inc. (the “Company” or “CEN”)

Form 10-12G, Amendment 1

File No.: 000-55557

 

Dear Ms. Hayes:


We are filing Amendment One to our Form 10-12G to clarify the record and distribution date for the anticipated spinoff of shares.


If you have any questions or require anything further, please feel free to call me at 226-344-0660.




Sincerely,


/s/ Bill Chaaban


Bill Chaaban

President







1